Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS application figures show a good upward trend
2008-10-23

Applications for admission to the University of the Free State (UFS) are showing an upward trend. In comparison with the same time last year, the total application figure has increased from 6 273 to 7 507 – a growth of 19,7%.

So far, applications for postgraduate studies are showing the biggest growth with 1 342 applications received. During the same time last year, 594 applications for postgraduate studies were received – an increase of 126%.

Prospective students have until 30 November 2008 to apply for admission. “This applies to first-time entering first-year students and senior students who have interrupted their studies for at least one year,” said Mr Vernon Collett, Registrar: Student Academic Services, at the UFS.

According to Mr Collett students whose applications for admission are received after 30 November 2008 and until 13 January 2009 will be accepted subject to the availability of place on the programme they applied for.

Applications from prospective students who wrote the Senior Certificate (prior to 2008) and who are in the possession of a conditional exemption will only be accepted until 5 January 2009.

Prospective students who want to apply must pay a non-refundable fee of R140.
The signed application form must be accompanied by a certified copy of the prospective student’s identity document or passport, a proof of payment of the application fee as well as a certified copy of their Statement of Results of their Senior Certificate.

Prospective students who are in Grade 12 this year will receive a National Senior Certificate. A certified copy of their Statement of Results must be faxed to the UFS not later than 7 January 2009.

The application form of a minor must be signed by his/her parent or guardian and the field of study should be clearly indicated.

First-time entering first-year students from the Faculties of Economic and Management Sciences and the Humanities (including Education) will be welcomed by the Acting Rector, Prof. Teuns Verschoor, on Friday, 9 January 2009 at 09:00 in the Callie Human Centre on the Main Campus.

The welcoming of students from the Faculties of Health Sciences, Natural and Agricultural Sciences, Law and Theology will take place on Saturday, 10 January 2009 at 09:00 in the Callie Human Centre.

The registration of first-time entering first-year students will commence on 13 January 2009 and that of senior students on 19 January 2009 at the Callie Human Centre according to a programme.

Students who applied for admission after 30 November 2008 and are accepted can register from 4 February 2009.

Lectures will commence on 2 February 2009 and the registration process will end on 10 February 2009. This is applicable to all students – undergraduate as well as postgraduates

Prospective students who want to apply for admission or who have any enquiries can call 051 401 3000 or visit the UFS web site at www.ufs.ac.za.

 

Media Release:
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
22 October 2008

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept